6SEPTEMBER - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe pharma space has always been prone to heightened regulatory scrutiny, but over the last year, regulatory mandates reached an all-time-high as the COVID-19 pandemic pushed organizations into digitalizing their deeply-rooted processes. This emerging stringency of compliance can be particularly witnessed in several areas including income and marketing practices, clinical trial data reporting, and patient privacy, among others. And as pharma businesses continue to cope with continuous tech advancements and their effective implementation, they are seeking partners that can assist them in traversing the ever-evolving compliance arena. In fact, a plethora of compliance solutions and services vendors are currently promising to help their clients establish an efficient compliance process by leveraging next-gen technologies. By leveraging emerging technologies such as AI and ML to automate cumbersome documentation processes and track trends in the compliance arena respectively.Currently, as the pharma space continues its tech-driven evolution, drug developers and manufacturers are driven to identify and decide on the most relevant technology solutions that are can help them seamlessly comply with upcoming mandates. To positively impact the entire spectrum of compliance, the need is to understand and envisage the right technologies for documentation management and real-time tracking of regulations. The right implementation and support of the most appropriate solution and services will spell success in the long run. Leafing through this edition of Pharma Tech Outlook will provide you with the valuable insights and strategies to effectively support pharma companies in ensuring compliance with the most stringent regulatory mandates in the most seamless and efficient way.Let us know your thoughts. Demystifying Pharma Compliance Copyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.SEPTEMBER - 13 - 2021, Vol 07 - Issue 09 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerJaxon JaseEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David ParkerTECH OUTLOOKTECH OUTLOOK
< Page 5 | Page 7 >